The survival kinases Akt and Pim as potential pharmacological targets

被引：359
|
作者：
Amaravadi, R [1 ]
Thompson, CB [1 ]
机构：
[1] Univ Penn, Abramson Family Canc Res Inst, Dept Canc Biol & Med, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CLINICAL INVESTIGATION | 2005年 / 115卷 / 10期
关键词：
D O I：
10.1172/JCI26273
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The Akt and Pim kinases are cytoplasmic serine/threonine kinases that control programmed cell death by phosphorylating substrates that regulate both apoptosis and cellular metabolism. The PI3K-dependent activation of the Akt kinases and the JAK/STAT-dependent induction of the Pim kinases are examples of partially overlapping survival kinase pathways. Pharmacological manipulation of such kinases could have a major impact on the treatment of a wide variety of human diseases including cancer, inflammatory disorders, and ischemic diseases.
引用
收藏
页码：2618 / 2624
页数：7
相关论文
共 50 条
  • [1] Oncogenic Pim family kinases as potential drug targets
    Sandholm, J
    Aho, T
    Rainio, EM
    Koskinen, PJ
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 28 : S27 - S27
  • [2] Oncogenic Pim family kinases as potential drug targets
    Sandholm, J.
    Aho, T.
    Rainio, E.
    Koskinen, P. J.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2007, 65 (06) : 606 - 606
  • [3] PIM Kinases as Potential Biomarkers and Therapeutic Targets in Inflammatory Arthritides
    Assirelli, Elisa
    Ciaffi, Jacopo
    Scorcu, Valentina
    Naldi, Susanna
    Brusi, Veronica
    Mancarella, Luana
    Lisi, Lucia
    Pignatti, Federica
    Ursini, Francesco
    Neri, Simona
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [4] The Pim Kinases: New Targets for Drug Development
    Swords, Ronan
    Kelly, Kevin
    Carew, Jennifer
    Nawrocki, Stefan
    Mahalingam, Devalingam
    Sarantopoulos, John
    Bearss, David
    Giles, Francis
    CURRENT DRUG TARGETS, 2011, 12 (14) : 2059 - 2066
  • [5] AKT kinases as therapeutic targets
    Hassan, Dalal
    Menges, Craig W.
    Testa, Joseph R.
    Bellacosa, Alfonso
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [6] PIM Kinases as Potential Therapeutic Targets in a Subset of Peripheral T Cell Lymphoma Cases
    Martin-Sanchez, Esperanza
    Odqvist, Lina
    Rodriguez-Pinilla, Socorro M.
    Sanchez-Beato, Margarita
    Roncador, Giovanna
    Dominguez-Gonzalez, Beatriz
    Blanco-Aparicio, Carmen
    Garcia Collazo, Ana M.
    Gonzalez Cantalapiedra, Esther
    Pastor Fernandez, Joaquin
    Curiel del Olmo, Soraya
    Pisonero, Helena
    Madureira, Rebeca
    Almaraz, Carmen
    Mollejo, Manuela
    Javier Alves, F.
    Menarguez, Javier
    Gonzalez-Palacios, Fernando
    Luis Rodriguez-Peralto, Jose
    Ortiz-Romero, Pablo L.
    Real, Francisco X.
    Garcia, Juan F.
    Bischoff, James R.
    Piris, Miguel A.
    PLOS ONE, 2014, 9 (11):
  • [7] PIM kinases as therapeutic targets against advanced melanoma
    Shannan, Batool
    Watters, Andrea
    Chen, Quan
    Mollin, Stefan
    Doerr, Markus
    Meggers, Eric
    Xu, Xiaowei
    Gimotty, Phyllis A.
    Perego, Michela
    Li, Ling
    Benci, Joseph
    Krepler, Clemens
    Brafford, Patricia
    Zhang, Jie
    Wei, Zhi
    Zhang, Gao
    Liu, Qin
    Yin, Xiangfan
    Nathanson, Katherine L.
    Herlyn, Meenhard
    Vultur, Adina
    ONCOTARGET, 2016, 7 (34) : 54897 - 54912
  • [8] Pim Kinases as Therapeutic Targets in Early Rheumatoid Arthritis
    Maney, Nicola J.
    Lemos, Henrique
    Barron-Millar, Ben
    Carey, Christopher
    Herron, Ian
    Anderson, Amy E.
    Mellor, Andrew L.
    Isaacs, John D.
    Pratt, Arthur G.
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (10) : 1820 - 1830
  • [9] Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma
    Schatz, Jonathan H.
    Oricchio, Elisa
    Wolfe, Andrew L.
    Jiang, Man
    Linkov, Irina
    Maragulia, Jocelyn
    Shi, Weiji
    Zhang, Zhigang
    Rajasekhar, Vinagolu K.
    Pagano, Nen C.
    Porco, John A., Jr.
    Teruya-Feldstein, Julie
    Rosen, Neal
    Zelenetz, Andrew D.
    Pelletier, Jerry
    Wendel, Hans-Guido
    JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (09): : 1799 - 1807
  • [10] Pim kinases are potential molecular targets in K-Ras mediated transformation of pancreatic cancer
    Cobb, Michael
    Allsop, Stephen
    Barnett, Annika
    Hall, Kashif
    Johnson, Desinia
    Parms, Tiffany
    Sanders, Arnicia
    Xu, Dapeng
    Chen, Xiaoxin
    Bednarski, Brian
    Kim, Hong
    Baldwin, Albert
    Baines, Antonio
    CANCER RESEARCH, 2009, 69
12345